Q2 2025 Earnings Estimate for Aspen Aerogels, Inc. Issued By Seaport Res Ptn (NYSE:ASPN)

Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) - Investment analysts at Seaport Res Ptn dropped their Q2 2025 earnings per share estimates for Aspen Aerogels in a research report issued to clients and investors on Monday, May 6th. Seaport Res Ptn analyst T. Curran now forecasts that the construction company will post earnings per share of $0.15 for the quarter, down from their prior forecast of $0.19. The consensus estimate for Aspen Aerogels' current full-year earnings is $0.03 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels' Q3 2025 earnings at $0.19 EPS and FY2025 earnings at $0.78 EPS.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.11. The business had revenue of $84.22 million for the quarter, compared to analyst estimates of $83.82 million. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. During the same quarter last year, the company earned ($0.20) EPS.

A number of other brokerages have also recently weighed in on ASPN. Canaccord Genuity Group boosted their price target on shares of Aspen Aerogels from $18.00 to $28.00 and gave the company a "buy" rating in a research report on Friday, May 3rd. Piper Sandler raised their price target on Aspen Aerogels from $20.00 to $29.00 and gave the stock an "overweight" rating in a research note on Friday, May 3rd. B. Riley boosted their price objective on Aspen Aerogels from $24.00 to $30.00 and gave the company a "buy" rating in a research note on Friday, May 3rd. HC Wainwright raised their target price on shares of Aspen Aerogels from $20.00 to $25.00 and gave the stock a "buy" rating in a research report on Friday, May 3rd. Finally, TheStreet upgraded shares of Aspen Aerogels from a "d+" rating to a "c-" rating in a research report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating and six have issued a buy rating to the stock. According to MarketBeat.com, Aspen Aerogels currently has an average rating of "Moderate Buy" and a consensus target price of $25.17.

Aspen Aerogels Stock Up 1.4 %

Shares of Aspen Aerogels stock traded up $0.37 during trading hours on Wednesday, hitting $26.64. The company had a trading volume of 1,297,146 shares, compared to its average volume of 1,120,329. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29. The company's 50-day moving average is $17.27 and its two-hundred day moving average is $14.13. The company has a market cap of $2.03 billion, a P/E ratio of -60.55 and a beta of 1.97. Aspen Aerogels has a twelve month low of $5.32 and a twelve month high of $27.09.

Insider Activity at Aspen Aerogels

In other news, SVP Corby C. Whitaker sold 55,159 shares of Aspen Aerogels stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $25.01, for a total value of $1,379,526.59. Following the sale, the senior vice president now owns 131,533 shares of the company's stock, valued at $3,289,640.33. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 4.30% of the stock is currently owned by insiders.

Institutional Trading of Aspen Aerogels

A number of institutional investors have recently modified their holdings of the business. Banque Cantonale Vaudoise boosted its position in shares of Aspen Aerogels by 37.5% during the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company's stock worth $81,000 after purchasing an additional 1,252 shares in the last quarter. Thompson Davis & CO. Inc. grew its position in Aspen Aerogels by 14.7% during the fourth quarter. Thompson Davis & CO. Inc. now owns 24,150 shares of the construction company's stock worth $381,000 after buying an additional 3,100 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Aspen Aerogels by 38.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company's stock valued at $205,000 after buying an additional 3,607 shares in the last quarter. Bouvel Investment Partners LLC lifted its position in shares of Aspen Aerogels by 4.3% during the 4th quarter. Bouvel Investment Partners LLC now owns 94,318 shares of the construction company's stock valued at $1,488,000 after acquiring an additional 3,929 shares during the period. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in shares of Aspen Aerogels by 7.1% during the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 84,257 shares of the construction company's stock worth $725,000 after acquiring an additional 5,611 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.